Dados B3 › CEPE5 × EQTL3
CEPE5 × EQTL3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | CEPE5 | EQTL3 | year |
|---|---|---|---|
| ROE | 31.3%! | 6.5% | 2025 |
| ROIC | 13.6%! | 9.3% | 2025 |
| ROA | 4.5% | 2.2% | 2025 |
| Gross margin | 22.2% | 26.1% | 2025 |
| EBIT margin | 15.6% | 15.6% | 2025 |
| Net margin | 7.6% | 4.8% | 2025 |
| Net debt/EBITDA | 4.28x | 3.90x | 2025 |
| Current ratio | 1.07x | 1.49x | 2025 |
| Revenue growth (1y) | 5.2% | 19.0% | 2025 |
| Revenue growth (5y CAGR) | 4.8% | 23.8% | 2025 |
| Piotroski F-Score | 6/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | CEPE5 | EQTL3 | year |
|---|---|---|---|
| P/E | 5.35x | 32.35x | 2021 × 2025 |
| P/B | 1.10x | 2.11x | 2021 × 2025 |
| EV/EBITDA | 6.20x | 8.72x | 2021 × 2025 |
| FCF yield | — | -7.6% | 2021 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 12:38 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 12:38 UTC. If this does not match /saude, you are reading a cached copy.